PMID- 29536637 OWN - NLM STAT- MEDLINE DCOM- 20181113 LR - 20181113 IS - 1865-1682 (Electronic) IS - 1865-1674 (Linking) VI - 65 IP - 5 DP - 2018 Oct TI - A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge. PG - 1227-1234 LID - 10.1111/tbed.12862 [doi] AB - The objective of this study was to determine the efficacy of a commercially available porcine reproductive and respiratory syndrome virus (PRRSV)-1 modified-live virus (MLV) vaccine against PRRSV-1 and PRRSV-2 challenge in late-term pregnancy gilts. Gilts were vaccinated with the PRRSV-1 MLV vaccine at 4 weeks prior to breeding and then challenged intranasally with PRRSV-1 or PRRSV-2 at 93 days of gestation. After PRRSV-1 challenge, vaccinated pregnant gilts had a significantly longer gestation period, significantly higher numbers of live-born and weaned piglets and a significantly lower number of stillborn piglets at birth compared to unvaccinated pregnant gilts. No significant improvement in reproductive performance was observed between vaccinated and unvaccinated pregnant gilts following PRRSV-2 challenge. Vaccinated pregnant gilts also exhibited a significantly improved reproductive performance after challenge with PRRSV-1 compared to vaccinated pregnant gilts following PRRSV-2 challenge. The PRRSV-1 MLV vaccine was able to reduce PRRSV-1 but not PRRSV-2 viremia in pregnant gilts. Vaccinated gilts also showed a significantly higher number of PRRSV-1-specific IFN-gamma-secreting cells (IFN-gamma-SC) compared to PRRSV-2-specific IFN-gamma-SC. The data presented here suggest that the vaccination of pregnant gilts with a PRRSV-1 MLV vaccine provides good protection against PRRSV-1 but only limited protection against PRRSV-2 challenge in late-term pregnancy gilts based on improvement of reproductive performance, reduction in viremia and induction of IFN-gamma-SC. CI - (c) 2018 Blackwell Verlag GmbH. FAU - Jeong, J AU - Jeong J AD - Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea. FAU - Kang, I AU - Kang I AD - Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea. FAU - Kim, S AU - Kim S AD - Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea. FAU - Park, S-J AU - Park SJ AD - Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea. FAU - Park, K H AU - Park KH AD - Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea. FAU - Oh, T AU - Oh T AD - Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea. FAU - Yang, S AU - Yang S AD - Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea. FAU - Chae, C AU - Chae C AUID- ORCID: 0000-0002-0190-1957 AD - Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea. LA - eng SI - GENBANK/JN315686 SI - GENBANK/JN315685 GR - Research Institute for Veterinary Science/ GR - College of Veterinary Medicine/ GR - 5260-20150100/BK 21 Plus Program/ PT - Journal Article DEP - 20180313 PL - Germany TA - Transbound Emerg Dis JT - Transboundary and emerging diseases JID - 101319538 RN - 0 (Antibodies, Viral) RN - 0 (Vaccines, Live, Unattenuated) RN - 0 (Viral Vaccines) SB - IM MH - Administration, Intranasal MH - Animals MH - Antibodies, Viral/blood MH - Female MH - Porcine Reproductive and Respiratory Syndrome/*prevention & control MH - Porcine respiratory and reproductive syndrome virus/*immunology MH - Pregnancy MH - Pregnancy Complications, Infectious/prevention & control/*veterinary MH - Reproduction MH - Stillbirth MH - Swine MH - Vaccination/*veterinary MH - Vaccines, Live, Unattenuated/immunology MH - Viral Vaccines/*administration & dosage/immunology MH - Viremia/immunology OTO - NOTNLM OT - modified-live virus vaccine OT - porcine reproductive and respiratory syndrome virus OT - reproductive failure OT - sow OT - vaccine EDAT- 2018/03/15 06:00 MHDA- 2018/11/14 06:00 CRDT- 2018/03/15 06:00 PHST- 2017/09/22 00:00 [received] PHST- 2018/03/15 06:00 [pubmed] PHST- 2018/11/14 06:00 [medline] PHST- 2018/03/15 06:00 [entrez] AID - 10.1111/tbed.12862 [doi] PST - ppublish SO - Transbound Emerg Dis. 2018 Oct;65(5):1227-1234. doi: 10.1111/tbed.12862. Epub 2018 Mar 13.